Aura Biosciences updates corporate deck for Jefferies conference; no material new data

Aura Biosciences, Inc.

Company conducting investor meetings at Jefferies Global Healthcare Conference starting June 5, 2024.
Updated corporate presentation filed as Exhibit 99.1; no specific financial or clinical updates disclosed.
No changes to guidance, pipeline milestones, or regulatory timelines announced.
Presentation includes forward-looking statements referencing risks in prior SEC filings.
Event is routine conference participation; no earnings or business combination.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.